0001437749-21-017256.txt : 20210721
0001437749-21-017256.hdr.sgml : 20210721
20210721083042
ACCESSION NUMBER: 0001437749-21-017256
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210709
FILED AS OF DATE: 20210721
DATE AS OF CHANGE: 20210721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehoux Lawrence
CENTRAL INDEX KEY: 0001873952
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55557
FILM NUMBER: 211102824
MAIL ADDRESS:
STREET 1: 11879 SOLOMAN ST
CITY: WINDSOR
STATE: A6
ZIP: N8P 1P1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEN BIOTECH INC
CENTRAL INDEX KEY: 0001653821
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
BUSINESS PHONE: 226-344-0660
MAIL ADDRESS:
STREET 1: 300-3295 QUALITY WAY
CITY: WINDSOR
STATE: A6
ZIP: N8T 3R9
3
1
rdgdoc.xml
FORM 3
X0206
3
2021-07-09
0
0001653821
CEN BIOTECH INC
CENBF
0001873952
Lehoux Lawrence
300-3295 QUALITY WAY
WINDSOR, ONTARIO, CANADA
A6
N8T 3R9
ONTARIO, CANADA
1
1
Chief Technology Officer
Common Stock
3030000
D
Lawrence Lehoux (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on July 9, 2021 and owned 3,030,000 shares of the Issuer's common stock at such date.
/s/ Lawrence Lehoux
2021-07-21